Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol vs Calcitriol in Postmenopausal Women with Low BMD or Mild Osteoporosis
NCT05902078Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eldecalcitol in postmenopausal osteoporosis and osteopenia (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Percent Change From Baseline in Bone Mineral Density at the Lumbar Spine at 12 months. Started Sep 2023; status: recruiting.
02
Drugs
eldecalcitol
03
Conditions
postmenopausal osteoporosisosteopenia
Beyond the preview
Go deeper on NCT05902078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05902078.